Deborah Miller

Yersiniabactin synthetase: a four-protein assembly line producing the nonribosomal peptide/polyketide hybrid siderophore of Yersinia pestis.

Peer and family support in children and adolescents with type 1 diabetes.

Clinical images: Epidural lipomatosis in a 14-year-old boy with systemic lupus erythematosus.

Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.

Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.

Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.

Cast adrift: Gortex cast liners allow greater patient activity.

Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

Challenges for nephrology nurses in the management of children with chronic kidney disease.

Association of fatigue and brain atrophy in multiple sclerosis.

Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.

Reflections on Haiti: love, warmth, and milk.

Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system.

Effect of entomopathogenic nematodes on Plectrodera scalator (Fabricius) (Coleoptera: Cerambycidae).

Laboratory evaluation of the toxicity of systemic insecticides for Control of Anoplophora glabripennis and Plectrodera scalator (Coleoptera: Cerambycidae).

Peritoneal dialysis as the treatment of choice for pediatric patients. CCPD is the therapy of choice for pediatric patients with ESRD.

Field evaluations of systemic insecticides for control of Anoplophora glabripennis (Coleoptera: Cerambycidae) in China.

Management of pediatric patients with chronic kidney disease.

One size does not fit all: using qualitative methods to inform the development of an Internet portal for multiple sclerosis patients.

Management of pediatric patients with chronic kidney disease.

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Endangered species indeed.

Health-related quality of life assessment in multiple sclerosis.

Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.

Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics.

Implementation of effective treatments of preschool behavior problems in a clinic setting.

"Clicker" technology promotes interactivity in an undergraduate nutrition course.

The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake.

Using an automated recruitment process to generate an unbiased study sample of multiple sclerosis patients.

Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life.

Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up.

Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Haiti revisited: the more things change, the more they stay the same.

Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure.

A methodology to establish a database to study gene environment interactions for childhood asthma.

Web-based self-management for patients with multiple sclerosis: a practical, randomized trial.

The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference.

Outcomes associated with introduction of a shoulder dystocia protocol.

Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.

The neurology quality-of-life measurement initiative.

Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations.

Self-management in neurological disorders: systematic review of the literature and potential interventions in multiple sclerosis care.

Contributions of private landowners to the conservation of the gopher tortoise (Gopherus polyphemus).

In assessing multiple sclerosis disease activity patient report measures are a waste of time: cut to the MRI scan!--No.

Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.

Associate residency training directors in psychiatry: demographics, professional activities, and job satisfaction.

Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers.

Interdisciplinary collaboration to maintain a culture of safety in a labor and delivery setting.

Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Clinical inquiries. Whom should you test for secondary causes of hypertension?

Disposition and metabolism of the cathepsin K inhibitor odanacatib in humans.

Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.

How does the FDA's drug approval process work?